Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Roundtable discussion: Incorporating bone marrow transplantation into NCCN guidelines.

W P Vaughan1, S M Silver, P G Beatty

  • 1Bone Marrow Transplantation Program, University of Alabama at Birmingham, USA.

Oncology (Williston Park, N.Y.)
|February 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

Bone marrow transplantation·2024
Same author

Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

Bone marrow transplantation·2024
Same author

Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes.

Leukemia research·2020
Same author

The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.

Bone marrow transplantation·2017
Same author

Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.

Leukemia·2017
Same author

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Leukemia·2017
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

A new National Comprehensive Cancer Network panel is standardizing bone marrow transplant guidelines. This ensures consistent, evidence-based use of autologous and allogeneic transplantation across cancer types, including hematologic malignancies and breast cancer.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • The National Comprehensive Cancer Network (NCCN) established a panel for bone marrow transplantation.
  • The panel aims to integrate allogeneic and autologous transplantation into NCCN guidelines where evidence supports their use.
  • Ensuring consistency in marrow transplantation recommendations across various cancer guidelines is a key objective.

Purpose of the Study:

  • To review and ensure the appropriate inclusion of bone marrow transplantation in NCCN guidelines.
  • To standardize the application of bone marrow transplantation across different hematologic malignancies and other cancers.
  • To address the need for guideline updates reflecting emerging evidence, particularly for autologous bone marrow transplantation in breast cancer.

Main Methods:

Related Experiment Videos

  • A preliminary review of existing NCCN guidelines was conducted.
  • Assessment of the current evidence supporting bone marrow transplantation in various hematologic malignancies.
  • Identification of areas requiring guideline refinement, such as lymphomas, multiple myeloma, and myelodysplasia.

Main Results:

  • Bone marrow transplantation is appropriately included for common adult hematologic malignancies: acute myeloid leukemia, chronic myeloid leukemia, myelodysplasia, multiple myeloma, Hodgkin's disease, and malignant lymphomas.
  • Refinements are needed for lymphomas, multiple myeloma, and myelodysplasia due to evolving data and definitions.
  • Growing evidence for autologous bone marrow transplantation in advanced and metastatic breast cancer necessitates guideline updates.

Conclusions:

  • The NCCN panel is working to standardize bone marrow transplantation guidelines.
  • Guidelines require frequent updates to reflect the latest evidence, especially for complex hematologic conditions and breast cancer.
  • Patient referral to well-designed clinical trials remains the standard of care for all bone marrow transplantations.